BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Teva Reports 2017 Full Year and Fourth Quarter Financial Results

  Revenues in 2017 were $22.4 billion, an increase of 2%, or 6% in local currency terms, compared to 2016.

  February 8, 2018

   · 

  50 min read
• Business

  Perrigo to Release Fourth Quarter and Calendar Year 2017 Financial Results On February 27, 2018

  Perrigo today announced that it will release its fourth quarter and calendar year 2017 financial results on Tuesday, February 27, 2018.

  February 8, 2018

   · 

  4 min read
• Business

  Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Period Activity

  At December 31, 2017, Alnylam had cash, cash equivalents and fixed income marketable securities, and restricted investments of $1.73 billion, as compared to $1.09 billion at December 31, 2016.

  February 8, 2018

   · 

  22 min read
• BioMidwest

  Dr. Gayle Kirkpatrick Joins rMark Bio’s Advisory Board

  rMark Bio is pleased to announce that Dr. Gayle Kirkpatrick has joined their Advisory board.

  February 8, 2018

   · 

  2 min read
• Deals

  Two Labs Acquires MKO Global Partners

  Two Labs, an industry-leading pharma and life science services company, today announced that it has acquired MKO Global Partners, a strategic global life sciences consulting firm focused on payer strategy, market access, and pricing in the pharmaceutical and biotech markets.

  February 8, 2018

   · 

  2 min read
• Pharm Country

  Novo Nordisk Launches Rebinyn in the United States for People With Hemophilia B

  Novo Nordisk today announced that Rebinyn, Coagulation Factor IX, GlycoPEGylated, is now available in the United States for the treatment of hemophilia B.

  February 8, 2018

   · 

  5 min read
• Policy

  60° Pharma Receives Priority Review Designation for Malaria Drug

  60 Degrees Pharma received Priority Review Designation from the USFDA for Tafenoquine for prevention of malaria in adults.

  February 8, 2018

   · 

  4 min read
• Business

  VWR and EPL Open New GxP Archive & Biorepository Facility

  The first facility opening on this campus offers over 155,000 square feet of new storage capacity, designed to support the full spectrum of EPL professional biorepository services.

  February 8, 2018

   · 

  2 min read
• 

  Drug Development

  Amicus Releases More Impressive Pompe Disease Data at WORLDSymposium

  The company presented a late-breaker poster and corresponding oral presentation at the conference.

  February 8, 2018

   · 

  10 min read
• Pharm Country

  BioWave’s Non-Opioid Smarter Pain Blocking Technology Now Available to All Branches of the United States Military

  BioWave’s FDA-cleared high frequency neurostimulation technology delivers soothing therapeutic signals through the skin into deep tissue, blocking pain signals at the source.

  February 8, 2018

   · 

  2 min read